China · Delayed Price · Currency is CNY Aurisco Pharmaceutical Statistics
Total Valuation
SHA:605116 has a market cap or net worth of CNY 7.75 billion. The enterprise value is 7.99 billion.
| Market Cap | 7.75B |
| Enterprise Value | 7.99B |
Important Dates
The last earnings date was Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | Jun 15, 2026 |
Share Statistics
SHA:605116 has 403.41 million shares outstanding. The number of shares has increased by 3.34% in one year.
| Current Share Class | 403.41M |
| Shares Outstanding | 403.41M |
| Shares Change (YoY) | +3.34% |
| Shares Change (QoQ) | +3.75% |
| Owned by Insiders (%) | 74.05% |
| Owned by Institutions (%) | 4.50% |
| Float | 91.33M |
Valuation Ratios
The trailing PE ratio is 21.07.
| PE Ratio | 21.07 |
| Forward PE | n/a |
| PS Ratio | 4.55 |
| PB Ratio | 2.89 |
| P/TBV Ratio | 3.08 |
| P/FCF Ratio | 300.97 |
| P/OCF Ratio | 18.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.38, with an EV/FCF ratio of 310.65.
| EV / Earnings | 21.43 |
| EV / Sales | 4.69 |
| EV / EBITDA | 12.38 |
| EV / EBIT | 16.52 |
| EV / FCF | 310.65 |
Financial Position
The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.36.
| Current Ratio | 4.16 |
| Quick Ratio | 2.59 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.50 |
| Debt / FCF | 37.69 |
| Interest Coverage | 13.94 |
Financial Efficiency
Return on equity (ROE) is 14.61% and return on invested capital (ROIC) is 14.57%.
| Return on Equity (ROE) | 14.61% |
| Return on Assets (ROA) | 7.49% |
| Return on Invested Capital (ROIC) | 14.57% |
| Return on Capital Employed (ROCE) | 13.00% |
| Weighted Average Cost of Capital (WACC) | 2.39% |
| Revenue Per Employee | 841,007 |
| Profits Per Employee | 184,134 |
| Employee Count | 2,026 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.16 |
Taxes
In the past 12 months, SHA:605116 has paid 62.22 million in taxes.
| Income Tax | 62.22M |
| Effective Tax Rate | 14.29% |
Stock Price Statistics
The stock price has decreased by -18.60% in the last 52 weeks. The beta is -0.35, so SHA:605116's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | -18.60% |
| 50-Day Moving Average | 19.98 |
| 200-Day Moving Average | 23.33 |
| Relative Strength Index (RSI) | 40.06 |
| Average Volume (20 Days) | 3,380,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605116 had revenue of CNY 1.70 billion and earned 373.06 million in profits. Earnings per share was 0.91.
| Revenue | 1.70B |
| Gross Profit | 960.47M |
| Operating Income | 484.02M |
| Pretax Income | 435.27M |
| Net Income | 373.06M |
| EBITDA | 639.91M |
| EBIT | 484.02M |
| Earnings Per Share (EPS) | 0.91 |
Balance Sheet
The company has 720.92 million in cash and 970.02 million in debt, with a net cash position of -249.10 million or -0.62 per share.
| Cash & Cash Equivalents | 720.92M |
| Total Debt | 970.02M |
| Net Cash | -249.10M |
| Net Cash Per Share | -0.62 |
| Equity (Book Value) | 2.68B |
| Book Value Per Share | 6.46 |
| Working Capital | 1.41B |
Cash Flow
In the last 12 months, operating cash flow was 413.89 million and capital expenditures -388.16 million, giving a free cash flow of 25.73 million.
| Operating Cash Flow | 413.89M |
| Capital Expenditures | -388.16M |
| Depreciation & Amortization | 155.89M |
| Net Borrowing | -50.49M |
| Free Cash Flow | 25.73M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 56.37%, with operating and profit margins of 28.41% and 21.89%.
| Gross Margin | 56.37% |
| Operating Margin | 28.41% |
| Pretax Margin | 25.55% |
| Profit Margin | 21.89% |
| EBITDA Margin | 37.56% |
| EBIT Margin | 28.41% |
| FCF Margin | 1.51% |
Dividends & Yields
This stock pays an annual dividend of 0.34, which amounts to a dividend yield of 1.71%.
| Dividend Per Share | 0.34 |
| Dividend Yield | 1.71% |
| Dividend Growth (YoY) | 17.24% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 38.65% |
| Buyback Yield | -3.34% |
| Shareholder Yield | -1.63% |
| Earnings Yield | 4.82% |
| FCF Yield | 0.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |